Mylan
Supplier — contracts won
£2.1bnTotal value£2,141,594,940 across every award on file
5Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 5 | £2.1bn |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 28 Oct 2024 | NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 | NHS England | Gilead Sciences Limited +12 | £626.5m |
| 25 Jun 2025 | NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | NHS England | Roche Products Ltd +27 | £261.9m |
| 16 Apr 2025 | NHS National Framework - Generics Housekeeping/Supply Chain Resilience ProductsEast Midlands | NHS England | Drugsrus Ltd +30 | £11.7m |
| 16 Jun 2025 | NHS National Generic Pharmaceuticals - ClozapineEngland | NHS England | Leyden Delta B.V. +2 | £1 |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.